Literature DB >> 11901068

Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.

Roshini S Abraham, Raynell J Clark, Sandra C Bryant, James F Lymp, Timothy Larson, Robert A Kyle, Jerry A Katzmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11901068

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  21 in total

1.  Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents.

Authors:  Sherry Mori; Brooke S Crawford; Julianna Vf Roddy; Gary Phillips; Pat Elder; Craig C Hofmeister; Yvonne Efebera; Don M Benson
Journal:  Hematol Oncol       Date:  2011-10-26       Impact factor: 5.271

Review 2.  Multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Curr Probl Cancer       Date:  2009 Jan-Feb       Impact factor: 3.187

3.  Appraisal of immunoglobulin free light chain as a marker of response.

Authors:  Angela Dispenzieri; Lijun Zhang; Jerry A Katzmann; Melissa Snyder; Emily Blood; Roberta Degoey; Kimberly Henderson; Robert A Kyle; Martin M Oken; Arthur R Bradwell; Philip R Greipp
Journal:  Blood       Date:  2008-03-25       Impact factor: 22.113

4.  Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

Authors:  V González-Calle; J Dávila; F Escalante; A G de Coca; C Aguilera; R López; A Bárez; J M Alonso; R Hernández; J M Hernández; P de la Fuente; N Puig; E M Ocio; N C Gutiérrez; R García-Sanz; M V Mateos
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

5.  The anion gap and routine serum protein measurements in monoclonal gammopathies.

Authors:  Karen H van Hoeven; Rosy E Joseph; William J Gaughan; Laura McBride; Elizabeth Bilotti; Ann McNeill; Linda Schmidt; Danielle Schillen; David S Siegel
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

6.  A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.

Authors:  Nelson Leung; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-18       Impact factor: 8.237

7.  Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies.

Authors:  Peter Mollee
Journal:  Clin Biochem Rev       Date:  2009-08

8.  Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.

Authors:  C L H Snozek; J A Katzmann; R A Kyle; A Dispenzieri; D R Larson; T M Therneau; L J Melton; S Kumar; P R Greipp; R J Clark; S V Rajkumar
Journal:  Leukemia       Date:  2008-07-03       Impact factor: 11.528

9.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Authors:  Colin A Hutchison; Stephen Harding; Pete Hewins; Graham P Mead; John Townsend; Arthur R Bradwell; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 10.  Current and future circulating biomarkers for cardiac amyloidosis.

Authors:  Marco Luciani; Luca Troncone; Federica Del Monte
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.